Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 20/20 | 0.79 |
| ▸ | F2 | P00734 | 4/20 | 0.79 |
| ▸ | F9 | P00740 | 1/20 | 0.48 |
| ▸ | PLAT | P00750 | 1/20 | 0.48 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6217600 | 0.91 | F10 (0.81) | F10F2F9PLATKLKB1 | |
| SCHEMBL6221223 | 0.91 | F10 (0.81) | F10F2F9PLATKLKB1 | |
| SCHEMBL948334 | 0.91 | F10 (0.76) | F10F2F9PLATKLKB1 | |
| SCHEMBL950594 | 0.88 | F10 (1.00) | F10F2F9PLATKLKB1 | |
| SCHEMBL949001 | 0.88 | F10 (1.00) | F10F2F9PLATKLKB1 | |
| SCHEMBL947904 | 0.88 | F10 (1.00) | F10F2F9PLATKLKB1 | |
| SCHEMBL948942 | 0.88 | F10 (0.80) | F10F2F9PLATKLKB1 | |
| Hydrochloric Acid SCHEMBL949099 | 0.88 | F10 (0.98) | F10F2F9PLATKLKB1 | |
| SCHEMBL5446139 | 0.87 | F10 (0.79) | F10F2F9PLATKLKB1 | |
| SCHEMBL949219 | 0.87 | F10 (0.79) | F10F2F9PLATKLKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110009389-A1 | IMIDAZOLE DERIVATIVE, THEIR PRODUCTION AND USE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009389-A1 | IMIDAZOLE DERIVATIVE, THEIR PRODUCTION AND USE | F2, H1-3, CYC1 | F10 490/4885F2 1/4885F9 60/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.